Berman, Devalerio & Pease LLP Announces Filing of Shareholder Suits Against Bristol-Myers Squibb --BMY--;.Business & Legal Editors BOSTON--(BUSINESS WIRE)--May 18, 2000 MICROSTRATEGY, INC inc - /ink/ increment, i.e. increase by one. Especially used by assembly programmers, as many assembly languages have an "inc" mnemonic. Antonym: dec. . (MSTR MSTR Microstrategy, Inc (stock symbol) MSTR Master MSTR Minneapolis and St. Louis (railroad) MSTR Master Mode ); SEROLOGICALS, INC. (SERO SERO Southeast Regional Office SERO Sekundaerrohstoffe (recycling, former GDR) SERO Syringe Exchange Resources Online SERO System Engineering/Engineer Release Order SERO Site Emergency Response Organisation (nuclear) ); SCB ScB abbr. Latin Scientiae Baccalaureus (Bachelor of Science) COMPUTER TECHNOLOGY, INC. (SCBI SCBI Sportfishing Club of the British Isles ); STONE & WEBSTER, INC. (SW) AND PACIFIC GATEWAY EXCHANGE, INC. (PGEX) REGARDING SHAREHOLDER LAWSUITS BY BERMAN, DEVALERIO & PEASE LLP LLP - Lower Layer Protocol Berman, DeValerio & Pease LLP, a law firm specializing in representing shareholders in class action lawsuits for almost twenty years, issues the following press release: If you purchased the securities of any of the companies listed below, you may be a member of the class and should consider contacting Berman, DeValerio & Pease, LLP to learn about your rights and interests in the case and ability to possibly recoup your losses. You can contact the firm at (800) 516-9926 or visit their website at http://www.bermanesq.com/: BRISTOL-MYER SQUIBB (NYSE NYSE See: New York Stock Exchange : BMY BMY Bristol Myers Squibb ) Bristol-Myers Squibb, Inc. and its CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. are charged with making false and misleading statements about the effectiveness of VANLEV in treating hypertension and its lack of side effects. If you purchased Bristol-Myers common stock during the period November 8, 1999 through April 19, 2000 and lost money, you may be eligible for inclusion in the class. MICROSTRATEGY, INC. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : MSTR) MicroStratey and certain of its officers are charged with prematurely recording revenues, in violation of GAAP GAAP See: Generally Accepted Accounting Principles GAAP See generally accepted accounting principles (GAAP). , and causing MicroStrategy's publicly reported revenues and earnings to be materially overstated. If you purchased MSTR common stock during the period June 11, 1998 to March 18, 2000 you may be part of the class. SEROLOGICALS, INC. (NASDAQ: SERO) Serologicals, Inc. is charged with overstating its publicly reported financial statements during 1999. Serologicals announced that it would be required to restate those financial statements as they failed to comply with GAAP. Investors who purchased Serologicals common stock during the period April 27, 1999 through April 10, 2000 and who suffered losses on their investments may be part of the class. SCB COMPUTER TECHNOLGY, INC. (NASDAQ: SCBI) SCB Computer Technology, Inc. and certain of its officers and directors are charged with issuing materially false and misleading financial statements. On April 13, 2000 SCB Computer announced that it would restate its 1998 and 1999 financial statements and that its outside auditors had resigned. Investors who purchased SCB Computer common stock during the period August 17, 1997 through April 13, 2000 and who lost money on their investment, may be eligible for inclusion in the class. STONE & WEBSTER, INC. (NYSE: SW) Stone & Webster is charged with issuing false financial statements during 1999 and concealing from investors its severely deteriorating financial condition. Purchasers of Stone & Webster's common stock during the period April 27, 1999 through April 28, 2000 who lost money on their investment may be eligible for inclusion in the class. PACIFIC GATEWAY EXCHANGE, INC. (NASDAQ: PGEX) Pacific Gateway Exchange, which is restating its 1999 financial results, is charged with issuing fales and misleading financial statements and misleading investors. If you purchased Pacific Gateway Exchange common stock during the period May 13, 1999 to March 31, 2000 you may be included in the case. Berman, DeValerio & Pease LLP, with offices in Boston and San Francisco, is one of the nation's leading firms in representing investors in securities class action lawsuits and has substantial experience in prosecuting class actions. The firm has been appointed lead counsel in many major shareholder lawsuits pending throughout the country. The firm prides itself on its responsiveness to shareholders and their needs in particular cases. If you are an investor in any of the actions listed above, or have any questions about any securities class action, please contact the firm at (800) 516-9926. Ask to speak to one of the attorneys handling the case you are seeking information about, or you may speak to Jeffrey C. Block, Esq., or Michael G. Lange, Esq. or you can also write to the firm at One Liberty Square, Boston, MA 02109, send the firm a facsimile at (617) 542-1194 or send the firm an e-mail at bdplaw@bermanesq.com To learn more about any of these cases, or class actions in general, you can visit our website at http://www.bermanesq.com/ |
|
||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion